07 Apr CannMed 2017 Sold Out. Live Web Stream Available
CannMed 2017 is officially sold out! But don’t worry. If you didn’t purchase your ticket, you can still enjoy all the presentations via live stream for $149. Just go to http://bit.ly/cannmed-registration and select the “Online Web Viewing” option.
We have two full days of content, across multiple topics. See the summary below.
Conference presentations and panels begin on Monday, April 10th at 9:00 a.m. with a featured address via Skype from Dr. Raphael Mechoulam titled The Endocannabinoid System: A Fifty-Year Trip. This followed by Dr. Alexandros Makriyannis speaking on The Endocannabinoid System – A Source for Drug Discovery, Dr. Anton Reiner sharing Use of CB2 Receptor Inverse Agonists in the Treatment of Traumatic Brain Injury, and Dr. Mark Scialdone covering Hydrogenated Cannabis Oil.
Late morning presentations will include Dr. Bonni Goldstein sharing her experience on How Patients Benefit from Medical Cannabis, Dr. John Gaitanis addressing A Clinician’s Approach to Managing Uncertainty in Medically Refractory Patients, and Dr. Deborah Malka speaking to Cannabis Therapeutic Use in the Elderly, followed by Kevin McKernan, Chief Science Officer of Courtagen Life Sciences, dialoguing on Portable genomics and the Open Source CNS (Cannabis Nomenclature System).
Following the lunch break, presentations will continue with Dr. Jonathan Page will present Elucidating Cannabinoid Biosynthesis Using Trichome Targeted Genomics, and Dr. Nolan Kane will discuss Cannabis Used in Research Does Not Reflect Legal Markets. The session will conclude with Lyn Ulbricht sharing A Mother’s Story: What is the Drug War, Really?
The afternoon session will proceed with Dr. Elizabeth Thiele addressing The Role of Cannabidiol in the Treatment of Refractory Pediatric Epilepsy. Dr. Orrin Devinsky will follow with a videotaped presentation on Cannabidiol (Epidiolex) in Dravet and Lennox-Gastaut Syndromes: Preliminary Clinical Trial Results. Dr. Douglas R. Smith will then present Toward Precision Medicine for Cannabidiol Treatment in Epilepsy, and the Impact of Rare Variation in Endocannabinoid System Genes, immediately followed by Dr. Fabricio Pamplona sharing the Potential Clinical Benefits of CBD-Enriched Extracts Over Purified CBD in Treatment-Resistant Epilepsy.
The conference will continue on Tuesday, April 11th with Dr. Michael Dor speaking on Israel, Leading a Process: From Illegal Substance to Potent Medication followed by Amir Golanand A Personal Story. Dr. Dustin Sulak will answer the question, Is Cannabis a Solution to the Opioid Epidemic? Dr. Jeffrey Hergenrather will round out the morning with Assertions vs. Evidence, Kindly Check Your Assertions at the Door.
Late morning presentations will include Dr. Debra Kimless sharing Case Presentations of Cancer Patients Treated with Low Dose Cannabis Oil Alone or in Combination with Conventional Therapy. Dr. David Meiri will follow with insight on Matching an Effective Cannabis Strain Extract for a Specific Subtype of Cancer. Mara Gordon will present on the Comparison of the Anti-Tumor Efficacy of a Whole-Plant Extract vs. Pure THC in Preclinical Models of HER2-Positive Breast Cancer, followed up by Sean McAllister speaking on Cannabinoids as Antitumor Agents: Moving Toward the Clinic.
Following the lunch break (which will include a panel discussion featuring attorneys Valerio Romano and Michael D. Cutler, with Dr. Bonni Goldstein, on How to Legally Recommend Cannabis to Your Patients), Dr. Sara Jane Ward will share her experience with Cannabinoids as Medicine: Pain and CNS Injury. Dr. Kent Crowley will then speak to the Impact of Standardized Cannabis Therapy in Chronic Non-cancer Pain with or without Opiate Use, followed by Dr. Jordan Tishler addressing Cannabis for Pain Management and Opioid Use Reduction.
The afternoon will include a featured panel discussion, Cannabis as Medicine in Professional Sports, led by Jim McAlpine and featuring former NFL players, Ricky Williams, Eben Britton, Nate Jackson, and Lance Johnstone. Dr. Perry Solomon and Dr. David Nathan will also share their medical experience and knowledge on the topic.
The conference will conclude with Dr. Staci Gruber presenting, It’s Not Easy Being Green: Assessing the Impact of Medical Marijuana on Cognition, Mood, Brain Function and Related Measures, Dr. Ryan Ravenelle sharing Automation Solutions for High Throughput Pesticides Analysis in Cannabis Labs and Dr. Christopher Hudalla speaking to Cannabis Contaminants: Practical Considerations vs. Regulatory Requirements.